Identification of specific gene expression profiles in fibroblasts derived from middle ear cholesteatoma

Archives of Otolaryngology - Head and Neck Surgery

Volumn 132, Issue 7, 2006, Pages 734-742

  Yoshikawa, Mamoru ^a   Kojima, Hiromi ^a   Wada, Kota ^a   Tsukidate, Toshiharu ^a   Okada, Naoko ^b   Saito, Hirohisa ^b   Moriyama, Hiroshi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; EPIREGULIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CELL CULTURE; CHOLESTEATOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; GENOME; HUMAN; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TYMPANOPLASTY; UNINDEXED SEQUENCE;

CHOLESTEATOMA, MIDDLE EAR; FIBROBLASTS; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33746132753     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.132.7.734     Document Type: Article

References (37)

1. Maas-Szabowski N, Shimotoyodome A, Fusenig NE. Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism. J Cell Sci. 1999;112(pt 12):1843-1853.
2. Szabowski A, Maas-Szabowski N, Andrecht S, et al. c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell. 2000;103:745-755.
3. El Ghalbzouri A, Lamme E, Ponec M. Crucial role of fibroblasts in regulating epidermal morphogenesis. Cell Tissue Res. 2002;310:189-199.
4. El-Ghalbzouri A, Gibbs S, Lamme E, Van Blitterswijk CA, Ponec M. Effect of fibroblasts on epidermal regeneration. Br J Dermatol. 2002;147:230-243.
5. Werner S, Smola H. Paracrine regulation of keratinocyte proliferation and differentiation. Trends Cell Biol. 2001;11:143-146.
6. Schilling V, Negri B, Bujia J, Schulz P, Kastenbauer E. Possible role of interleukin 1α and interleukin 1β in the pathogenesis of cholesteatoma of the middle ear. Am J Otol. 1992;13:350-355.
7. Chung JW, Yoon TH. Different production of interleukin-1α, interleukin-1β and interleukin-8 from cholesteatomatous and normal epithelium. Acta Otolaryngol. 1998;118:386-391.
8. Yetiser S, Satar B, Aydin N. Expression of epidermal growth factor, tumor necrosis factor-α, and interleukin-1α in chronic otitis media with or without cholesteatoma. Otol Neurotol. 2002;23:647-652.
9. Waterston RH, Lindblad-Toh K, Birney E, et al. Initial sequencing and analysis of the human genome [published corrections appear in Nature. 2001;412:565 and Nature. 2001;411:720]. Nature. 2001;409:860-921.
10. Drews J. Drug discovery: a historical perspective. Science. 2000;287:1960-1964.
11. Hopkins AL, Groom CR. The druggable genome. Nat Rev Drug Discov. 2002;1:727-730.
12. Iida M, Matsumoto K, Tomita H, et al. Selective down-regulation of high-affinity IgE receptor (FcεRI) α-chain messenger RNA among transcriptome in cord blood-derived versus adult peripheral blood-derived cultured human mast cells. Blood. 2001;97:1016-1022.
13. Brouty-Boye D, Pottin-Clemenceau C, Doucet C, Jasmin C, Azzarone B. Chemokines and CD40 expression in human fibroblasts. Eur J Immunol. 2000;30:914-919.
14. Hogaboam CM, Steinhauser ML, Chensue SW, Kunkel SL. Novel roles for chemokines and fibroblasts in interstitial fibrosis. Kidney Int. 1998;54:2152-2159.
15. Pap T, Muller-Ladner U, Gay RE, Gay S. Fibroblast biology. Arthritis Res. 2000;2:361-367.
16. Park CC, Bissell MJ, Barcellos-Hoff MH. The influence of the microenvironment on the malignant phenotype. Mol Med Today. 2000;6:324-329.
17. Silzle T, Kreutz M, Dobler MA, Brockhoff G, Knuechel R, Kunz-Schughart LA. Tumor-associated fibroblasts recruit blood monocytes into tumor tissue. Eur J Immunol. 2003;33:1311-1320.
18. Smith RS, Smith TJ, Blieden TM, Phipps RP. Fibroblasts as sentinel cells. Am J Pathol. 1997;151:317-322.
19. Silzle T, Randolph GJ, Kreutz M, Kunz-Schughart LA. The fibroblast: sentinel cell and local immune modulator in tumor tissue. Int J Cancer. 2004;108:173-180.
20. Roth M, Johnson PR, Borger P, et al. Dysfunctional interaction of C/EBPα and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. N Engl J Med. 2004;351:560-574.
21. Sudhoff H, Dazert S, Gonzales AM, et al. Angiogenesis and angiogenic growth factors in middle ear cholesteatoma. Am J Otol. 2000;21:793-798.
22. Shiwa M, Kojima H, Moriyama H. Expression of transforming growth factor-α (TGF-α) in cholesteatoma. J Laryngol Otol. 1998;112:750-754.
23. Tanaka Y, Shiwa M, Kojima H, Miyazaki H, Kamide Y, Moriyama H. A study on epidermal proliferation ability in cholesteatoma. Laryngoscope. 1998;108:537-542.
24. Ergun S, Zheng X, Carlsoo B. Expression of transforming growth factor-α and epidermal growth factor receptor in middle ear cholesteatoma. Am J Otol. 1996;17:393-396.
25. Schulz P, Bujia J, Holly A, Shilling V, Kastenbauer E. Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor α. Am J Otolaryngol. 1993;14:82-87.
26. Toyoda H, Komurasaki T, Uchida D, et al. Epireregulin: a novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem. 1995;270:7495-7500.
27. Shirakata Y, Komurasaki T, Toyoda H, et al. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J Biol Chem. 2000;275:5748-5753.
28. Hashimoto K. Regulation of keratinocyte function by growth factors. J Dermatol Sci. 2000;24(suppl 1):S46-S50.
29. Greaves DR, Wang W, Dairaghi DJ, et al. CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3α and is highly expressed in human dendritic cells. J Exp Med. 1997;186:837-844.
30. Power CA, Church DJ, Meyer A, et al. Cloning and characterization of a specific receptor for the novel CC chemokine. MIP-3α from lung dendritic cells. J Exp Med. 1997;186:825-835.
31. Charbonnier AS, Kohrgruber N, Kriehuber E, Stingl G, Rot A, Maurer D. Macrophage inflammatory protein 3α is involved in the constitutive trafficking of epidermal Langerhans cells. J Exp Med. 1999;190:1755-1768.
32. Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, Farber JM. CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3α. J Immunol. 1999;162:186-194.
33. Ruth JH, Shahrara S, Park CC, et al. Role of macrophage inflammatory protein-3α and its ligand CCR6 in rheumatoid arthritis. Lab Invest. 2003;83:579-588.
34. Matsui T, Akahoshi T, Namai R, et al. Selective recruitment of CCR6-expressing cells by increased production of MIP-3α in rheumatoid arthritis. Clin Exp Immunol. 2001;125:155-161.
35. Akimoto R, Pawankar R, Yagi T, Baba S. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesion molecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec. 2000;62:257-265.
36. Shinoda H, Huang CC. Localization of intercellular adhesion molecule-1 in middle ear cholesteatoma. Eur Arch Otorhinolaryngol. 1995;252:385-390.
37. Bujia J, Holly A, Kim C, Scanady N, Kastenbauer E. Expression of human intercellular adhesion molecules in middle ear cholesteatoma. Am J Otolaryngol. 1994;15:271-275.